(Q70218169)
Statements
A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapy (English)
R V Smalley
A A Bartolucci
D Burns
C A Presant